about
Betulinic acid is a PPARγ antagonist that improves glucose uptake, promotes osteogenesis and inhibits adipogenesis.Genistein induces adipogenic differentiation in human bone marrow mesenchymal stem cells and suppresses their osteogenic potential by upregulating PPARγ.Human Bone Marrow Stromal Cells: A Reliable, Challenging Tool for In Vitro Osteogenesis and Bone Tissue Engineering ApproachesShort-Term Hypoxia Accelerates Bone Loss in Ovariectomized Rats by Suppressing Osteoblastogenesis but Enhancing Osteoclastogenesis.Differentially expressed genes in PPARγ-deficient MSCs.Systematic analysis of lncRNAs, miRNAs and mRNAs for the identification of biomarkers for osteoporosis in the mandible of ovariectomized miceCMHX008, a PPARγ partial agonist, enhances insulin sensitivity with minor influences on bone loss
P2860
Q33916179-AFCFB526-D5CC-4F12-962B-A28F44A9AFC1Q36824552-00E97530-9DC8-4B69-866C-0538150D4876Q36933040-189816F9-F024-494D-A464-C2E5C26E53B6Q37221652-640BD7F0-6582-4800-BE61-B5C7E6F2F2FCQ38642592-2960D087-108A-4F09-9893-92EA17FA4046Q38676358-5EEB107F-E0B6-4C89-82D9-F7DF56E4E829Q57497106-BDEDED52-4E50-46BE-A8B8-8588452499B0
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Impact of targeted PPARγ disruption on bone remodeling.
@ast
Impact of targeted PPARγ disruption on bone remodeling.
@en
type
label
Impact of targeted PPARγ disruption on bone remodeling.
@ast
Impact of targeted PPARγ disruption on bone remodeling.
@en
prefLabel
Impact of targeted PPARγ disruption on bone remodeling.
@ast
Impact of targeted PPARγ disruption on bone remodeling.
@en
P2093
P2860
P1476
Impact of targeted PPARγ disruption on bone remodeling.
@en
P2093
Barbara E Kream
Kehong Ding
Mark W Hamrick
Nianlan Yang
P2860
P356
10.1016/J.MCE.2015.01.045
P577
2015-02-07T00:00:00Z